The Optos California, an ultra-widefield retinal imaging system designed for the tabletop, is equipped with the company’s new retinal imaging modality, indocyanine green angiography. The system was ...
Please provide your email address to receive an email when new articles are posted on . Toku’s BioAge software will be integrated into ultra-widefield retinal imaging devices from Optos. BioAge can ...
A Hattiesburg, Mississippi, eye doctor, Dr. David Richardson, first used Optos Optopmap retinal imaging camera last May to examine a picture of his own eye. What he saw, according to Hattiesburg ...
UK-based retinal imaging company Optos, which sells a variety of optics-based systems for diagnosing eye diseases, has won a “UK PLC” award recognizing its technology development. Part-organized by ...
KINGWOOD, TX--(Marketwired - November 21, 2016) - This November Vision Source and Optos are proud to highlight innovative advancements in diabetic eye care in honor of National Diabetes Awareness ...
LONDON, Feb 27 (Reuters) - Nikon, the 98-year-old Japanese company best known for its cameras, has agreed to buy British retinal imaging firm Optos (Other OTC: OPOSF - news) for 259.3 million pounds ...
Optos, the Scottish eyecare specialist and rising technology star, yesterday said it had added a third device to its range, and that the new product was aimed at the needs of an important customer ...
Optos has unveiled a £10 million collaboration with NHS Greater Glasgow and Clyde and the universities of Kent and Strathclyd to develop a new imaging technology that could allow earlier detection of ...
"While Optos and Spectralis are comparable for measuring GA in clinical trials and patient monitoring, the two modalities are not interchangeable. Clinicians and researchers should stick to one ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results